mEPSC frequency at D2-MSNs in the shell 24 hrs following the final drug exposure. Further, drug 48 re-exposure 10-14 days following a preference-inducing regimen of morphine produced a rapid 49 and enduring endocytosis of GluA2-containing AMPARs at D1-MSNs in the shell, that when 50 blocked by an intra-NAc shell infusion of the Tat-GluA23Y peptide, increased reinstatement of 51 morphine place preferencea phenomenon distinctly different than effects previously found with 52 cocaine. The present study is the first to directly identify unique circuit specific adaptations in NAc 53 glutamate synaptic transmission associated with morphine-related acute reward and somatic 54 withdrawal as well as post-abstinence short-term plasticity. While differing classes of abused 55 drugs (i.e., psychostimulants and opioids) produce seemingly similar bidirectional plasticity in the 56
NAc following exposure to relapse-linked stimuli, our findings indicate this plasticity has distinct 57 behavioral consequences. 58
INTRODUCTION 60
Opioids are the main class of drugs for pain management despite the risk for abuse (Wise 1989) . 61
In addition to their primary rewarding effects, repeated use of opioids can result in the 62 development of physical dependence that manifests as debilitating somatic and psychological 63 withdrawal symptoms that can perpetuate continued use (Koob et al. 1989; van Ree et al. 1999) . 64
Increasing evidence suggests that opioid-induced plasticity related to tolerance, dependence, and 65 withdrawal occurs within divergent, as well as overlapping, neural circuits as plasticity responsible 66 for establishing opioid-seeking behavior and drug-associated stimuli that can provoke craving and heterogeneous area of the brain divided into NAc core (NAcC) and shell (NAcSh) subregions 78 based on anatomical connectivity. While the NAcC subregion interacts with brain regions 79 associated with motor circuitry, thus coordinating behavioral output, the NAcSh interacts with 80 limbic and autonomic brain regions, indicating significant regulation of reward, emotional, and 81 visceral responses to stimuli (Everitt et al. 1999; Heimer et al. 1991; Zahm and Brog 1992) . Within 82 each subregion, the primary target of excitatory glutamate afferents are the principal medium Further, while elevations in NAc shell GluA1-containing AMPA-type receptors has recently been 91 shown to causally contribute to morphine dependence increases expression of GluA1-containing 92 AMPA-type receptors (Russell et al. 2016 Conditioned Place Preference. All conditioned place preference experiments employed a two-160 chamber apparatus (St. Albans, VT, USA) and were performed as previously described (Wydeven 161 et al. 2014 ). For conditioning, subjects were injected with morphine (5 mg/kg) or vehicle, and after 162 a 20-min delay were confined for 30 min in the corresponding CS+/CS− chamber. Morphine 163 dosing for place preference training was chosen based on previous findings that this dose 164 produces robust place preference (Hearing et al., 2016) . Further, this dose in addition to 165 extinction training following conditioning was shown to produce identical cell-specific plasticity 166 observed following 5 daily injections of morphine and home cage abstinence (Hearing et al. 167 2016) . A total of four morphine (5 mg/kg) and four saline trials were performed in alternating 168 fashion, with only one trial performed per day and preference evaluated 24 hrs following the final 169 conditioning session. Following conditioning, mice underwent 6 daily extinction sessions as 170 previously described (Hearing et al. 2016) , with animals confined to the CS+ and CS-171 compartment for 20 min each on days 1, 3, and 5 (extinction training) and allowed to freely explore 172 on days 2, 4, and 6 (extinction testing). Day 6 data was used for two-way ANOVA analysis. 173 174 Intra-cranial GluA2 peptide and reinstatement of place preference. Experimental treatments for 175 the reinstatement tests were assigned after extinction training and assignments were made to 176 ensure that each treatment group had similar preference scores prior to and following extinction. and withdrawal studies as previously described (Hearing et al. 2016 ). Slices were collected in in 199 a high sucrose solution as previously described (Hearing et al. 2013 ) and allowed to recover for 200 at least 45-60 min in ACSF solution saturated with 95% O2/5% CO2 containing (in mM) 119 NaCl, . This is significant given our observed plasticity 3 hrs, but not 24 hrs after a single 330 injection of morphine. Surprisingly, no studies to date have examined cell-or region-specific NAc 331 plasticity associated with spontaneous somatic withdrawal despite a purported role in relapse 332 behavior. In order to assess adaptations associated with spontaneous withdrawal and determine 333 whether plasticity is uniquely different following a similar withdrawal period (24 hrs) but a different 334 regimen, we administered an escalating dose of morphine shown to produce dependence as 335 drug challenge studies. Two-way day-by-drug ANOVA with day a repeated measure and drug 346 exposure as a between subjects factor reveal significant main effects of day (F(1,13)=10.52, 347 p<0.01), drug (F(1,13)=4.481, p=0.05), and a significant day-by-drug interaction (F(1,13)=12.08, 348 p<0.01). Bonferroni post hoc analyses showed no significant impact of day on saline-exposed 349 mice (p=0.99) but a significant decrease in withdrawal score after 14-day abstinence in morphine-350 exposed mice (p<0.001). 351
To identify plasticity that parallel withdrawal symptoms, we measured mEPSCs at D1-and (1.9±0.33), t(14)=1.536, p=0.15]. Taken together, these findings suggest that, similar to naloxone-363 precipitated withdrawal (Zhu et al. 2016 ), spontaneous somatic withdrawal selectively increases 364 excitatory drive at D2-MSNs in the NAcSh and that these effects are more enduring than 365 previously known. Further, these data support the notion that adaptations 10-14 d following a less 366 robust morphine regimen (5 x 10 mg/kg) or lack thereof 24 hrs following acute exposure is not 367 associated with enduring somatic withdrawal, and that the lack of plasticity observed 24 hrs 368 following an acute injection is distinctly different from withdrawal associated plasticity at a similar 369 timepoint. A Two-way ANOVA with test day as a repeated measure and treatment group as a between 388 subjects factor revealed a significant day-by-treatment interaction (F(6,135)=2.84, p<0.05). Post hoc 389 pairwise multiple comparisons showed that all three groups exhibited significant place preference 390 compared to pre-test preference levels, and that preference did not significantly differ across all 391 three groups during pre-test, preference, or extinction. For reinstatement testing, mice infused 392 with the inactive Tat-GluA23S peptide receiving a morphine prime displayed a significant increase 393 in preference compared to Tat-GluA23Y infused mice injected with saline ( Figure 4B1 Here we identify temporal-and region-specific changes in AMPAR signaling within discrete 409 subpopulations of NAc MSNs associated with opioid reward, withdrawal, and relapse-like 410 behavior. In agreement with our previous findings, we showed that protracted withdrawal from 411 repeated morphine is associated with increases in synaptic drive at D1-and decreases at D2-412
MSNs predominantly in the NAcSh (Hearing et al. 2016 ). Similar to amphetamine and cocaine 413 that expression of AMPARs is decreased in the NAcC 3 days following an acute morphine 429 exposure (Jacobs et al. 2005 ) and that GluA1 surface expression is reduced in combined NAc 430 tissue 24 hrs following acute exposure (Herrold et al. 2013 ). In the present study, we found that 431
AMPAR-mediated mEPSC amplitude and frequency was elevated at D1-MSNs in the NAcC and 432
NAcSh 3 hrs following an acute injection of morphine. Unlike previous studies, this time course 433 aligns with residual motor activity following drug exposure as well as the acute rewarding effects changes to amplitude in the present study may reflect distinctions in the time of observation (30 490 min vs. 24 hrs) or method of withdrawal (precipitated vs spontaneous). Alternatively, because 491 mEPSCs likely reflect binding at receptors in the synapse, it is possible that reduced surface 492 expression detected using biochemical measures (e.g., biotinylation) reflect sampling from 493 synaptic and peri/extra-synaptic AMPARs that have been primed but not trafficked to or from the 494 postsynaptic density. 495
Our previous findings show that 10-14 days after repeated morphine increases expression of 498
GluA2-lacking AMPARs at pooled inputs to D1-MSNs while reducing excitatory drive at D2-MSNs 499 in the NAcSh and NAcC (Hearing et al. 2016 ). In the present study, we also observed reductions 500 in mEPSC frequency at NAcC D2-MSNs, but only a trend towards reduced signaling at NAcSh 501 D2-MSNs. The prominence of plasticity in the NAcSh vs NAcC appears to contrast effects of 502 repeated cocaine, but is consistent with findings following 10-14 d withdrawal from repeated 503 amphetamine (Jedynak et al. 2016) , however these effects have not been readily characterized 504 in D1-vs D2-MSNs. In the current study, reductions in AMPAR signaling following morphine re-505 exposure were ostensibly isolated to D1-MSNs ( Figure 1B) . In turn, morphine treated mice infused 506 with the active Tat peptide in the NAcSh exhibited increased mEPSC amplitudes compared to 507 those infused with the inactive form ( Figure 4B ). Thus, morphine re-exposure likely triggers 508 endocytosis of synaptic GluA2-containing AMPARs in NAcSh D1-MSNs. Further, as the Tat 509 peptide inhibits activity-dependent rather than constitutive removal of synaptic GluA2-containing 510
AMPARs, this endocytosis is more likely to reflect a rapid, LTD-like process than a slow and 511 It should be noted that the precision of Tat injections in the current study was not specific with 514 regards to the rostral-caudal and dorsal-ventral axis. This is significant as prior work has shown 515 distinctions in how NAcSh cell subpopulations and AMPAR signaling along the dorsal-ventral and 516 rostro-caudal gradient differentially regulate reward-and aversive-driven behavior (Reynolds and 517 Berridge 2003) . As our recordings were primarily, but not exclusively, focused within the dorsal-518 medial region with even distribution along the rostral-caudal axis, it will be important for future 519 studies to examine anatomical distinctions when identifying causality between plasticity and 520 behavior. 521
Our current findings indicate that re-exposure to morphine promotes of AMPAR endocytosis 522 specifically at D1-MSN synapses previously potentiated during withdrawal from morphine, 523 however it is possible that reductions in synaptic strength may be occurring at adjacent, rather 524 than previously potentiated synapsesa possibility difficult to demonstrate definitively. Further, 525
although it is impossible to exclude, it is unlikely that inclusion of extinction produced alternate 526 plasticity in CPP studies compared to those observed in challenge experiments involving home 527 cage abstinence, as our previous work showed identical cell-specific plasticity in mice following 528 home cage abstinence and extinction. While the significance of this bimodal phenomenon is not 529 yet clear, one intriguing possibility is that re-exposure to opioids may represent a temporary 530 quelling of drug craving and in turn a trend towards returning to prior levels of D1-MSN excitation. 531
Role of bidirectional plasticity in reinstatement 533
Our previous work showed that in vivo reversal of morphine-induced pathophysiology at NAcSh 534 D1-MSNs with optogenetic stimulation or treatment with the antibiotic, ceftriaxone, blocked 535 reinstatement of morphine-evoked place preference (Hearing et al. 2016) . One straightforward 536 interpretation of these findings is that a progressive enhancement of AMPAR signaling during 537 withdrawal serves as a common mechanism for driving addiction-related behavior (Kalivas 2009 ; place preference, thus, unlike cocaine, increased expression of AMPAR during abstinence 553 appears to be the primary driver of reinstatement, with internalization of AMPARs following 554 morphine re-exposure perhaps reflecting a secondary synaptic scaling (Turrigiano 2008) in 555 response to augmented glutamate release, but see (Siahposht-Khachaki et al. 2017). Regardless, 556 these findings show that although two distinct drug classes can produce seemingly similar forms 557 of plasticity, the behavioral consequences of this plasticity appear to be profoundly different. 558 559
Conclusion 560
Though psychostimulants and opioids share rewarding properties that can lead to uncontrollable 561 drug use and relapse vulnerability, opioids are addictive substances with the ability to induce 562 chemical dependence from which relapse is driven by attempts to alleviate somatic and 563 psychological withdrawal symptoms. By modeling dosing regimens in a preclinical setting, we 564 sought to parallel acute, repeated, and dependence-inducing opioid consumption. Analysis of 565 AMPAR signaling from each dosing revealed unique and overlapping neuroplasticity to excitatory 566 signaling at NAcSh and NAcC MSNs. Future therapeutic interventions should take into 567 consideration that drug-induced neuroplasticity shared across drug classes does not inherently 568 share functional consequences at the level of the neural circuit or in terms of behavior. Thus, 569 more thorough characterization of opioid-induced plasticity is needed to provide more efficient 570 and effective therapies for opioid use disorder. 571 
